Gliclazide-d4
CAS: 1185039-30-8
Ref. 3D-FG29889
| 1mg | Discontinued | ||
| 2mg | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued |
Product Information
Name:
Gliclazide-d4
Description:
Gliclazide-d4 is a high-potency, long-acting insulin secretagogue that belongs to the group of sulfonylureas. It has been shown in animal studies to increase pancreatic β cell mass and improve insulin sensitivity. Gliclazide-d4 has been shown to be more potent than other sulfonylurea medications, and it has a pharmacological effect on blood glucose levels by stimulating the release of insulin from the pancreas. Gliclazide-d4 is metabolized in the liver by cytochrome P450 enzymes and excreted through urine. It also binds to receptors on the surface of cells, which may contribute to its effects on lowering blood glucose levels.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
438.24 g/mol
Formula:
C15H17D4V3O3S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
